Robin A. van der Meulen

Robin A. van der Meulen

Partner
New York

Robin represents businesses, public pension funds, and end-payor plaintiffs in complex antitrust and commodities class actions, challenging monopolies, price fixing cartels, and other anticompetitive conduct.

Robin represents businesses, public pension funds, and end-payor plaintiffs in complex antitrust and commodities class actions, challenging monopolies, price fixing cartels, and other anticompetitive conduct.

Overview

Robin A. van der Meulen is a partner in DiCello Levitt’s New York office, where she represents clients in complex antitrust litigation. Prior to joining DiCello Levitt, Robin was a partner in a nationally recognized antitrust practice group, where she gained more than a decade of experience litigating a wide variety of antitrust matters, including price-fixing, monopolization, benchmark and commodities manipulation, pay-for-delay agreements, and other anticompetitive practices.

Robin was appointed co-lead class counsel for end-payor plaintiffs in the Bystolic Antitrust Litigation, a pay-for-delay case pending in the Southern District of New York. She is also leading Borozny, et al. v. RTX, Pratt & Whitney Division, et al., a case alleging that six corporations in the aerospace industry conspired to restrict competition in the recruitment and hiring of engineers and other skilled workers. She recently recovered $30 million for end-payor plaintiffs in Novartis and Par Antitrust Litigation, another pay-for-delay case relating to the hypertension drug Exforge. Robin also represents end-payor plaintiffs in the Generic Pharmaceuticals Pricing Antitrust Litigation, a massive case against some of the biggest drug companies in the world alleging price-fixing and anticompetitive conspiracies.

Euromoney’s Women in Business Law Awards selected Robin as a finalist for Antitrust and Competition Lawyer of the Year. The Legal 500 recommends her for excellence in the field of Antitrust Civil Litigation and Class Actions, describing her as “persistent, persuasive, and well-respected by peers and opponents alike” and naming her a “Next Generation Partner.” Robin has been recognized as “Up and Coming” by Chambers USA and as a “Future Star” by Benchmark Litigation. She has also been selected to Benchmark’s “40 & Under Hot List” as one of “the best and brightest law firm partners” and someone who is “ready to take the reins.” Additionally, Robin was recognized by The Best Lawyers in America® in the Antitrust Law category.

Robin is an active member of the antitrust bar. She is the vice chair and a member of the Executive Committee of the Antitrust Law Section of the New York State Bar Association. Robin is also co-chair of the Insurance and Financial Services Committee of the Antitrust Section of the American Bar Association (ABA). Robin was previously a vice chair of the Antitrust Section’s Health Care & Pharmaceutical Committee of the ABA and the Executive Editor of the Committee’s Antitrust Health Care Chronicle. From 2012 to 2021, Robin was an editor of the Health Care Antitrust Week-In-Review, a weekly publication that summarizes antitrust news in the healthcare industry.

Robin was previously an associate at Willkie Farr & Gallagher LLP, where she practiced antitrust and commercial litigation. She also served as a judicial intern in the United States Bankruptcy Court for the Eastern District of New York for Judge Elizabeth S. Stong. While in college, Robin was a member of Columbia University’s Division I Track and Field team, specializing in hurdles and sprints.

Education

Brooklyn Law School, J.D.

Columbia College, Columbia University, B.A.

Education

Brooklyn Law School, J.D.

Columbia College, Columbia University, B.A.